Disc Medicine (IRON) Current Assets (2020 - 2026)
Disc Medicine (IRON) posted quarterly Current Assets of $732.8 million for Q2 2026, up 10.76% year-over-year from $661.6 million in Q2 2025, and down 1.97% quarter-over-quarter from $747.5 million in Q1 2026.
Analysis
Disc Medicine (IRON) Current Assets (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Current Assets for 7 consecutive years, with $732.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Assets rose 10.76% year-over-year to $732.8 million; the TTM figure through Jun 2026 stood at $732.8 million (up 10.76% YoY), while the FY2025 annual figure was $803.9 million, up 62.86% from the prior year.
- Current Assets fell to $732.8 million in Q2 2026 per IRON's latest filing, from $747.5 million in the prior quarter.
- Across five years, Current Assets topped out at $803.9 million in Q4 2025 and bottomed at $104.7 million in Q3 2022.
- Historically, Current Assets has averaged $446.1 million across 5 years, with a median of $437.4 million in 2023.
- Annual changes were most pronounced in 2022 — Current Assets plunged 34.22% — and 2023, when it soared 257.59%.
- Disc Medicine's Current Assets stood at $198.5 million in 2022, then surged by 84.22% to $365.7 million in 2023, then soared by 34.99% to $493.6 million in 2024, then soared by 62.86% to $803.9 million in 2025, then decreased by 8.85% to $732.8 million in 2026.
- Business Quant data shows IRON's Current Assets at $732.8 million in Q2 2026, $747.5 million in Q1 2026, and $803.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.82 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.03 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.76 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Disc Medicine | 3.06 Bn | 3.06 Bn | - | 732.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 732.76 Mn |
| Mar 31, 2026 | 747.46 Mn |
| Dec 31, 2025 | 803.90 Mn |
| Sep 30, 2025 | 627.17 Mn |
| Jun 30, 2025 | 661.59 Mn |
| Mar 31, 2025 | 705.60 Mn |
| Dec 31, 2024 | 493.62 Mn |
| Sep 30, 2024 | 493.15 Mn |
| Jun 30, 2024 | 508.24 Mn |
| Mar 31, 2024 | 351.95 Mn |
| Dec 31, 2023 | 365.66 Mn |
| Sep 30, 2023 | 374.26 Mn |
| Jun 30, 2023 | 381.73 Mn |
| Mar 31, 2023 | 242.14 Mn |
| Dec 31, 2022 | 198.49 Mn |
| Sep 30, 2022 | 104.66 Mn |
| Jun 30, 2022 | 113.13 Mn |
| Mar 31, 2022 | 124.07 Mn |
| Dec 31, 2021 | 90.48 Mn |
| Sep 30, 2021 | 154.80 Mn |